New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 3, 2014
09:56 EDTCMA, END, LAZ, NFX, RSPP, RGDO, RMD, SBGLOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Comerica (CMA) downgraded to Neutral from Buy at Citigroup... Endeavour (END) downgraded to Market Perform from Outperform at FBR Capital... Lazard (LAZ) downgraded to Outperform from Strong Buy at Raymond James... Newfield Exploration (NFX) downgraded to Hold from Buy at Societe Generale... RSP Permian (RSPP) downgraded to Neutral from Buy at UBS... Regado Biosciences (RGDO) downgraded to Underperform from Outperform at Wedbush... ResMed (RMD) downgraded to Hold from Buy at Deutsche Bank... Sibanye Gold (SBGL) downgraded to Sell from Neutral at UBS.
Check below for free stories on CMA;END;LAZ;NFX;RSPP;RGDO;RMD;SBGL the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 25, 2014
09:01 EDTRSPPRSP Permian agrees to acquire Midland Basin assets for $259M
Subscribe for More Information
05:49 EDTENDStocks with implied volatility movement; SODA END
Subscribe for More Information
July 24, 2014
07:05 EDTLAZLazard reports Q2 adjusted EPS 64c, consensus 57c
Subscribe for More Information
July 21, 2014
10:02 EDTRSPPOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:15 EDTRMDITC rules redesigned APEX humidifier infringes ResMed patents
An ITC ruling issued Friday held that, despite a redesign of its iCH CPAP device, Taiwanese device manufacturer APEX continues to infringe ResMed patents in its humidification. The original ITC action filed by ResMed in March 2013 asserted patent infringement by four products: APEX iCH and XT Fit CPAP humidifiers, the WiZARD 220 full face mask, and the WiZARD 210 nasal mask. In July 2013, APEX agreed to entry of an order prohibiting it from infringing ResMed's patents. And as a result, APEX has been banned from selling infringing products in the United States. APEX then redesigned its products and sought a ruling that it had avoided ResMed's patents. In this new ruling, the full commission held that the APEX iCH humidifier continues to infringe. As a result, APEX should continue to be banned from selling the iCH humidifier in the United States. The redesigned APEX XT Fit was found not to infringe. But APEX's expert stated that the redesigned humidifiers compromised on functionality and performance. The redesigned WiZARD 220 full face mask which now has a fused elbow instead of the more desirable detachable elbow -- was found not to infringe on ResMed patents. Again, APEX's expert noted that the redesigned masks sacrificed functional advantages present in the ResMed products. Finally, APEX chose to withdraw its redesigned WiZARD 210 nasal mask from these proceedings, so the July 2013 order remains in place as to that product.
07:32 EDTRSPPRSP Permian upgraded to Buy from Accumulate at KLR Group
KLR Group upgraded RSP Permian to Buy citing the company's production growth and "superior" capital yield. The firm raised its price target for shares to $42 from $34.
July 18, 2014
06:47 EDTNFXNewfield Exploration removed from short-term buy list at Deutsche Bank
Subscribe for More Information
July 17, 2014
09:04 EDTRSPPRSP Permian raises 2014 production outlook to 11,500-12,000 Boe/d
Raises 2014 CapEx to approximately $425M. Expects to fund it through a combination of cash and cash equivalents, operating cash flow, borrowings under RSP's revolving credit facility, and potential debt capital markets transactions.
09:04 EDTRSPPRSP Permian reports Q2 average daily production up 15% to 10,714 Boe/d
Subscribe for More Information
08:11 EDTNFXNewfield Exploration raises FY14 production to 46.5-48.5 MMBoe from 44-48 MMBoe
Newfield expects that its planned 2014 domestic capital investments will total about $1.7B from $1.6B. The additional investments specifically relate to improved drilling performance across the company and the addition of new acreage in the Anadarko Basin. Due to continued operational efficiencies, Newfield expects to drill up to 15 additional gross wells across its focus areas in 2014. Newfield's net production from continuing operations in the second quarter of 2014 was 12.1 MMBOE from 10.7 11.3 MMBOE. Liquids comprised approximately 55% of second quarter production volumes. Net liftings from discontinued operations totaled less than 0.1 MMBOE. Domestic production in the second quarter increased 12% over the first quarter of 2014 and 21% over the comparable quarter of 2013. Domestic liquids production in the second quarter of 2014 increased 13% over the first quarter of 2014 and 40% over the comparable quarter of 2013.
July 16, 2014
10:00 EDTCMAOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:33 EDTCMAComerica upgraded to Neutral from Underperform at Macquarie
Macquarie upgraded Comerica to Neutral following the better than expected Q2 report citing improving loan growth and potential rate catalysts. Price target is $50.
July 15, 2014
12:56 EDTCMAComerica upgraded to Buy from Hold at Rafferty Capital
Subscribe for More Information
06:49 EDTCMAComerica reports Q2 EPS 80c, consensus 76c
Subscribe for More Information
July 14, 2014
15:24 EDTCMANotable companies reporting before tomorrow's open
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use